Open-label olanzapine in obsessive-compulsive disorder refractory to antidepressant treatment

被引：23
|
作者：
Crocq, MA [1 ]
Leclercq, P [1 ]
Guillon, MS [1 ]
Bailey, PE [1 ]
机构：
[1] Ctr Hosp, F-68250 Rouffach, France
来源：
EUROPEAN PSYCHIATRY | 2002年 / 17卷 / 05期
关键词：
olanzapine; obsessive-compulsive disorder; augmentation therapy; treatment-unresponsive OCD;
D O I：
10.1016/S0924-9338(02)00673-9
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：296 / 297
页数：2
相关论文
共 50 条
  • [21] Perospirone augmentation of paroxetine in treatment of refractory obsessive-compulsive disorder with depression
    Otsuka, Tatsui
    Togo, Takashi
    Sugiyama, Naoya
    Uehara, Kumi
    Yoshimi, Asuka
    Karashima, Aya
    Shioya, Hiromi
    Hirayasu, Yoshio
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2007, 31 (02): : 564 - 566
  • [22] Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs. Generalized Anxiety Disorder: An Open-Label Trial
    Feusner, Jamie D.
    Kerwin, Lauren
    Saxena, Sanjaya
    Bystritsky, Alexander
    PSYCHOPHARMACOLOGY BULLETIN, 2009, 42 (01) : 81 - 93
  • [23] Open-label study of high (30 mg) and moderate (20 mg) dose escitalopram for the treatment of obsessive-compulsive disorder
    Dougherty, Darin D.
    Jameson, Mariko
    Deckersbach, Thilo
    Loh, Rebecca
    Thompson-Hollands, Johanna
    Jenike, Michael
    Keuthen, Nancy J.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2009, 24 (06) : 306 - 311
  • [24] Aripiprazole Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: a 10-Week Open-Label Study
    Ak, Mehmet
    Bulut, Suheyla Dogan
    Bozkurt, Ali
    Ozsahin, Aytekin
    ADVANCES IN THERAPY, 2011, 28 (04) : 341 - 348
  • [25] Rituximab as an adjunctive treatment for schizophrenia spectrum disorder or obsessive-compulsive disorder: Two open-label pilot studies on treatment-resistant patients
    Bejerot, Susanne
    Stein, Sofia Sigra
    Welin, Elisabet
    Eklund, Daniel
    Hylen, Ulrika
    Humble, Mats B.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2023, 158 : 319 - 329
  • [26] Effects of Ketamine in Treatment-Refractory Obsessive-Compulsive Disorder
    Bloch, Michael H.
    Wasylink, Suzanne
    Landeros-Weisenberger, Angeli
    Panza, Kaitlyn E.
    Billingslea, Eileen
    Leckman, James F.
    Krystal, John H.
    Bhagwagar, Zubin
    Sanacora, Gerard
    Pittenger, Christopher
    BIOLOGICAL PSYCHIATRY, 2012, 72 (11) : 964 - 970
  • [27] Therapeutic approaches to the treatment of refractory obsessive-compulsive disorder.
    Kochan L.D.
    Qureshi A.I.
    Fallon B.A.
    Current Psychiatry Reports, 2000, 2 (4) : 327 - 334
  • [28] Sarcosine Therapy for Obsessive Compulsive Disorder A Prospective, Open-Label Study
    Wu, Po-Lun
    Tang, Hwa-Sheng
    Lane, Hsien-Yuan
    Tsai, Chen-An
    Tsai, Guochuan E.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 31 (03) : 369 - 374
  • [29] Pharmacogenetics of antidepressant treatment in obsessive-compulsive disorder: an update and implications for clinicians
    Zai, Gwyneth
    Brandl, Eva J.
    Mueller, Daniel J.
    Richter, Margaret A.
    Kennedy, James L.
    PHARMACOGENOMICS, 2014, 15 (08) : 1147 - 1157
  • [30] ECT Use in Refractory Obsessive-Compulsive Disorder
    Tomruk, Nesrin B.
    Saatcioglu, Omer
    Ugurlu, Esra
    Hacioglu, Muenevver
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 20 (02): : 167 - 170
12345